NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

45 hedge funds and large institutions have $31.6M invested in NeuBase Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$12K
Puts
$51K
Net Calls
Net Calls Change

Top Sellers

1 -$1.27M
2 -$756K
3 -$396K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$391K
5
Two Sigma Investments
Two Sigma Investments
New York
-$310K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$7.66M
2
$3.83M
3
$3.51M
4
$2.81M
5
$2.64M
6
$2.55M
7
$1.78M
8
$1.2M
9
$874K
10
$685K
11
$644K
12
$422K
13
$344K
14
$281K
15
$245K
16
$232K
17
$220K
18
$196K
19
$163K
20
$154K
21
$150K
22
$136K
23
$113K
24
$94K
25
$84K